Atogepant + Rifampin Interaction
Moderateinteraction on record
Description
Strong CYP3A4 inducer and OATP1B1/OATP1B3 inhibitor resulting in significant decrease in atogepant exposure; dosage adjustment and monitoring for reduced efficacy recommended.
Mechanism
CYP3A4 induction and OATP inhibition
Source: NLP:atogepant